About us

iBody Inc. is a start-up company launched from Nagoya University, Japan, at Feb 2018.
We have pioneered a unique technology of discovering, generating, and producing monoclonal antibodies from single B cells.

Our mission is to contribute human healthcare by lightning monoclonal antibody development.

Name

iBody Inc.

Office

102 Incubation Facility, Nagoya University,

1 Furo-cho, Chikusa-ku, Nagoya, Aichi 464-0814, JAPAN  

​Capital

60,000,000 yen

Established

Feb. 1st, 2018

​Officers

CEO Yo Amakusa 

CSO Shoji Ohuchi Ph.D. 

Technical Adviser

Yoshihiro Kakeji Ph.D. (Professor, Kobe University)

Shun'ichi Kuroda Ph.D. (Professor, Osaka University)

​Kouhei Tsumoto Ph.D. (Professor, The University of Tokyo)

Hideo Nakano Ph.D. (Professor, Nagoya University)

会社所在地 

〒464-0814

愛知県名古屋市千種区不老町1番

​名古屋大学インキュベーション施設102号

Access

102 Incubation Facility, Nagoya University, 1 Furo-cho, Chikusa-ku, Nagoya, Aichi 464-0814, JAPAN 

お問い合わせ / Contact

info@ibody.co.jp

Copyright ©2020 iBody Inc All Rights Reserved.